Clinical Trial: A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07785830) titled 'A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)' on Aug. 21.

Brief Summary: Researchers are looking for new treatments for people living with HIV-1 (Human Immunodeficiency Virus Type 1). HIV-1 is the most common type of HIV, which is a virus that attacks cells of the immune system.

MK-4646 is a trial medicine designed to treat HIV-1. Before giving a trial medicine to people with a health condition, researchers first do studies in healthy participants.

The goals of this trial are to learn:

* What happens to rosuvastatin in a participant's body over time when it is taken wit...